BerganKDV Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$976K Sell
2,081
-53
-2% -$22.2K 0.1% 135
2023
Q1
$733K Buy
2,134
+5
+0.2% +$1.69K 0.08% 150
2022
Q4
$779K Sell
2,129
-46
-2% -$16.3K 0.08% 141
2022
Q3
$703K Sell
2,175
-16
-0.7% -$5.07K 0.08% 141
2022
Q2
$710K Hold
2,191
0.08% 143
2022
Q1
$627K Buy
2,191
+3
+0.1% +$772 0.07% 168
2021
Q4
$605K Buy
2,188
+26
+1% +$6.59K 0.06% 175
2021
Q3
$500K Buy
2,162
+250
+13% +$61.7K 0.06% 181
2021
Q2
$439K Buy
1,912
+34
+2% +$6.83K 0.05% 188
2021
Q1
$351K Sell
1,878
-2
-0.1% -$391 0.05% 194
2020
Q4
$317K Buy
1,880
+17
+0.9% +$2.54K 0.04% 186
2020
Q3
$276K Sell
1,863
-103
-5% -$15.9K 0.04% 193
2020
Q2
$323K Buy
1,966
+242
+14% +$37.1K 0.06% 188
2020
Q1
$239K Hold
1,724
0.05% 195
2019
Q4
$227K Buy
1,724
+43
+3% +$4.98K 0.04% 212
2019
Q3
$188K Sell
1,681
-2,900
-63% -$323K 0.04% 211
2019
Q2
$508K Hold
4,581
0.1% 139
2019
Q1
$594K Buy
4,581
+2,900
+173% +$353K 0.12% 122
2018
Q4
$195K Hold
1,681
0.05% 186
2018
Q3
$180K Sell
1,681
-12
-0.7% -$1.2K 0.04% 208
2018
Q2
$144K Buy
+1,693
New +$139K 0.03% 222
2017
Q2
Sell
-4,276
Closed -$360K 177
2017
Q1
$360K Sell
4,276
-127
-3% -$10.2K 0.11% 133
2016
Q4
$324K Buy
4,403
+402
+10% +$29.9K 0.11% 133
2016
Q3
$321K Sell
4,001
-500
-11% -$40K 0.11% 132
2016
Q2
$354K Buy
4,501
+495
+12% +$37.3K 0.15% 118
2016
Q1
$288K Buy
+4,006
New +$303K 0.17% 124

Other funds holding LLY

BerganKDV Wealth Management's LLY Position: Q2 2023 in Review

BerganKDV Wealth Management reduced its Eli Lilly (LLY) stake by 2.5% in Q2 2023, selling an estimated $22.2K and leaving 2,081 shares worth $976K. The position accounts for 0.1% of the portfolio, ranked #135.

BerganKDV Wealth Management first reported a position in LLY in Q1 2016 and has held it in 26 quarters since. 2,814 funds tracked by Wall St. Rank hold LLY as of Q2 2023.

  • BerganKDV Wealth Management held 2,081 shares of Eli Lilly worth $976K as of Q2 2023.
  • BerganKDV Wealth Management sold 53 Eli Lilly shares in Q2 2023, an estimated $22.2K.
  • Eli Lilly made up 0.1% of BerganKDV Wealth Management's portfolio in Q2 2023, its #135 holding.
  • BerganKDV Wealth Management first reported a position in Eli Lilly in Q1 2016 and has held it in 26 quarters since.
  • 2,814 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.